Journal article
Health‐Related Quality of Life in Survivors of High‐Risk Neuroblastoma After Stem Cell Transplant: A National Population‐Based Perspective
Abstract
PURPOSE: This study aimed to estimate the burden of morbidity, in terms of health-related quality of life (HRQL), in survivors of high-risk neuroblastoma (NBL) after myeloablative chemotherapy followed by autologous hematopoietic stem cell transplant (HSCT).
PATIENTS AND METHODS: A national population-based survey was undertaken of survivors of high-risk NBL (N = 99), diagnosed between 1991 and 2010 and treated with HSCT. Parents completed a …
Authors
Portwine C; Rae C; Davis J; Teira P; Schechter T; Lewis V; Mitchell D; Wall DA; Pullenayegum E; Barr RD
Journal
Pediatric Blood & Cancer, Vol. 63, No. 9, pp. 1615–1621
Publisher
Wiley
Publication Date
9 2016
DOI
10.1002/pbc.26063
ISSN
1545-5009